<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-72648</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Closure of perivalvular leaks using an amplatzer occluder</dc:title>
<dc:description xml:lang="en">Reoperation of patients with perivalvular leaks due to heart failure or hemolysis is associated with increased morbidity and mortality. Percutaneous closure using an Amplatzer device offers a promising alternative. We describe our initial experience between 2004 and 2006, during which we used an Amplatzer device in 8 patients for the percutaneous closure of perivalvular leaks (4 aortic and 4 mitral). The patients were all symptomatic and had a high surgical risk. Device placement was successful in all patients with mitral leaks and in 3 with aortic leaks. There were no periprocedural complications. With 4 of the 7 (57%) device placements, there was a significant reduction in the degree of regurgitation and, at 12-month follow-up, only these 4 patients showed clinical improvements. Of the other 3, 1 required reoperation and 2 died of non-cardiovascular causes. Percutaneous closure of perivalvular leaks was feasible and safe and can be regarded as a treatment option in patients with a high surgical risk (AU)</dc:description>
<dc:creator>Rodríguez-Bailón, Isabel</dc:creator>
<dc:creator>Teresa-Galván, Eduardo de</dc:creator>
<dc:creator>Domínguez-Franco, Antonio J</dc:creator>
<dc:creator>Alonso-Briales, Juan H</dc:creator>
<dc:creator>Muñoz-García, Antonio  J</dc:creator>
<dc:creator>Jiménez-Navarro, Manuel F</dc:creator>
<dc:creator>Hernández-García, José M</dc:creator>
<dc:creator>Melero-Tejedor, José M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La reintervención de los pacientes con fugas perivalvulares por insuficiencia cardiaca o hemolisis está asociada a una elevada morbimortalidad. La utilización percutánea de los dispositivos Amplatzer supone una alternativa atractiva. Presentamos nuestra experiencia inicial: entre 2004 y 2006 realizamos cierre percutáneo con dispositivo Amplatzer a 8 pacientes con fugas perivalvulares (4 aórticas y 4 mitrales), sintomáticos y con alto riesgo quirúrgico. La implantación del dispositivo fue posible en todas las mitrales y en 3 aórticas. No hubo complicaciones durante el procedimiento. En 4 (57%) de los 7 implantes se logró una reducción significativa del grado de regurgitación y, tras 12 meses de seguimiento, solamente estos pacientes mejoraron clínicamente. De los 3 restantes, 1 paciente precisó reintervención y 2 fallecieron por causa no cardiovascular. El tratamiento percutáneo de las fugas perivalvulares es factible y seguro y puede considerarse como una opción terapéutica en subgrupos de alto riesgo quirúrgico (AU)</dc:description>
<dc:source>Rev Esp Cardiol;62(4): 442-446, abr. 2009. ilus, tab</dc:source>
<dc:identifier>ibc-72648</dc:identifier>
<dc:title xml:lang="es">Utilización de los dispositivos Amplatzer para el cierre de fugas perivalvulares</dc:title>
<dc:subject>^d9133^s22032</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9133^s29166</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d12508</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d13906</dc:subject>
<dc:subject>^d22488^s22074</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d9133^s22016</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:subject>^d6501^s22009</dc:subject>
<dc:subject>^d9133^s22009</dc:subject>
<dc:type>article</dc:type>
<dc:date>200904</dc:date>
</metadata>
</record>
</ibecs-document>
